Skip to content Skip to sidebar Skip to footer

Newsletter

Charlie Youlden

Charlie is an Associate Equity Research Analyst covering ASX small caps across technology, mining and industrials.

His investing journey began in 2020 with large-cap US technology stocks, before he went on to complete a Commerce degree in Finance and Marketing at UTS, the Wall Street Prep Financial Modelling course, and Columbia Business School’s Value Investing course.

Charlie’s goal is to make investing clear, digestible and genuinely useful for everyday retail investors, helping them make better decisions with more confidence.

666 articles published

Small Caps Stocks Technology

Metal Powder Works (ASX: MPW) Falls 14% — Growing Pains or a Setup for Long-Term Gains?

Metal Powder Works Plunges 14% as Growth Story Faces Reality Check Metal Powder Works (ASX: MPW) took a sharp fall this morning, sliding 14.5 percent after releasing its full year results. For a stock that has been riding the wave of a strong growth story and delivering on milestones, today’s reaction raises the question of…

ByCharlie YouldenAugust 29, 20250Comments

Airlines Large Caps

Qantas (ASX:QAN) Soars 9% on FY25 Results as Revenue Hits A$23.8 Billion

Investors Reward Qantas as Recovery Turns Into Renewed Momentum Qantas (ASX:QAN) surged 9 percent today after unveiling its FY25 results, a remarkable turnaround for a company that was once on the brink during the depths of the pandemic. For long-term investors who held through the turbulence of 2020, the stock has now delivered close to…

ByCharlie YouldenAugust 28, 20250Comments

Healthcare Stocks Market news Tech Stocks

Why Telix (ASX:TLX) Fell 20% After FDA News – And What Investors Should Know

When expectations fall short, sentiment can shift in an instant. That is exactly what happened with Telix Pharmaceuticals (ASX: TLX) after the company received an unexpected setback from the U.S. Food and Drug Administration. TLX had applied for approval of TLX250-CDx, an innovative imaging agent designed to help doctors more accurately diagnose kidney…

ByCharlie YouldenAugust 28, 20250Comments

Small Caps Stocks Tech Stocks Technology

Inside Weebit Nano’s 333% Revenue Surge and the Future of ReRAM

Is This the Inflection Point Investors Have Been Waiting For? Weebit Nano (ASX:WBT) opened this morning with a 6% gain, a move that signals growing confidence among investors in the company’s ReRAM memory technology. The rise comes on the back of a strong annual report that showed revenues climbing to A$4.4 million, representing year-on-year growth…

ByCharlie YouldenAugust 28, 20250Comments

Technology

NVIDIA (NASDAQ: NVDA) Q2 Results: The Numbers Behind Its Biggest Leap Yet

NVIDIA’s Blackwell Boom: The Chip Redefining the Future of AI and Investor Growth NVIDIA (NASDAQ: NVDA) once again surprised markets with another earnings beat, posting second-quarter revenue of US$46.7 billion, up 6 percent from last quarter and 56 percent from a year ago. The market was slightly disappointed with the outlook for Q3, though. For…

ByCharlie YouldenAugust 28, 20250Comments

Mining Stocks

Vital Metals (ASX: VML) Surges 26% on US-Backed Funding Deal

Vital Metals Secures Strategic US Backing in Rare Earths Breakthrough Vital Metals (ASX: VML) caught investors’ attention today with its share price jumping 26 percent after the company announced a A$6.8 million strategic placement that brings a major US partner on board. At the heart of the news is not just fresh capital but a…

ByCharlie YouldenAugust 26, 20250Comments

Mining Stocks Small Caps Stocks Technology

Metal Powder Works (ASX: MPW): Can This 900% Winner Keep Its Momentum?

Why Metal Powder Works (ASX: MPW) Has Become One of the ASX’s Hottest Stocks Metal Powder Works (ASX: MPW) has become one of the most surprising small-cap stories on the ASX, with the stock surging nearly 889 percent in the past year. In a space where many companies struggle to gain momentum, MPW has captured…

ByCharlie YouldenAugust 26, 20250Comments

Healthcare Stocks Technology

Why Investors Are Watching Nanosonics (ASX: NAN) After a Strong Earnings Surge

Is CORIS the Catalyst for Nanosonics’ (ASX: NAN) Next Phase of Expansion? Nanosonics (ASX: NAN) has caught the market’s attention, with its share price climbing 14 percent over the past week as excitement built ahead of its full-year results. The earnings release did not disappoint, giving investors fresh confidence in the company’s long-term growth story. At…

ByCharlie YouldenAugust 26, 20250Comments

Large Caps

Coles Jumps on Full-Year Results: What Investors Need to Know

Coles (ASX: COL): Stability Today, Efficiency Gains Tomorrow Coles Group (ASX: COL) opened the day up nearly 4 percent at $21 after releasing its full year results, and the reaction tells us something important about how investors see this company. In a market where volatility and uncertainty dominate the headlines, Coles is being treated as a…

ByCharlie YouldenAugust 26, 20250Comments

Mining Stocks Technology

Metallium (ASX:MTM): From 900% Growth to U.S. Policy Tailwinds – What’s Next?

Metallium (ASX: MTM): Chasing a Rare Earths Breakthrough Metallium Limited (ASX: MTM) sits at the center of one of the most pressing issues in global markets today. Rare earth elements are critical to everything from electric vehicles to defense systems, yet nearly 90 percent of processing remains concentrated in China. That control gives Beijing extraordinary pricing…

ByCharlie YouldenAugust 26, 20250Comments